Clinical Trial Update: The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial to assess safety, tolerability, and pharmacokinetics of a single-dose long-acting injectable brexpiprazole in healthy subjects and in i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Brexpiprazole long-acting injection (brexpiprazole)

Snippet

Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. | Conditions: Schizophrenia Disorders | Phase 1 | Status: RECRUITING